Jefferies Financial Group Lowers Teladoc Health (NYSE:TDOC) Price Target to $8.00

Teladoc Health (NYSE:TDOC - Free Report) had its price objective trimmed by Jefferies Financial Group from $10.00 to $8.00 in a research note released on Monday morning,Benzinga reports. The firm currently has a hold rating on the health services provider's stock.

Several other equities research analysts have also recently issued reports on TDOC. Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Royal Bank of Canada lifted their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Piper Sandler reduced their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Finally, Bank of America reduced their target price on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $10.82.

Teladoc Health Stock Performance

Shares of Teladoc Health stock traded up $0.16 during trading hours on Monday, hitting $7.23. 298,722 shares of the company were exchanged, compared to its average volume of 7,145,048. The business has a 50-day moving average of $8.78 and a 200-day moving average of $9.59. The stock has a market capitalization of $1.27 billion, a price-to-earnings ratio of -1.25 and a beta of 1.73. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. As a group, analysts expect that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.95% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Arizona State Retirement System raised its position in Teladoc Health by 1.8% in the 4th quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider's stock valued at $452,000 after purchasing an additional 859 shares during the last quarter. Mercer Global Advisors Inc. ADV grew its stake in Teladoc Health by 9.6% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider's stock valued at $113,000 after acquiring an additional 1,089 shares during the period. Canada Pension Plan Investment Board grew its stake in Teladoc Health by 0.5% in the fourth quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider's stock valued at $2,079,000 after acquiring an additional 1,200 shares during the period. Summit Investment Advisors Inc. grew its stake in shares of Teladoc Health by 8.0% during the 4th quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider's stock worth $164,000 after acquiring an additional 1,331 shares in the last quarter. Finally, Vise Technologies Inc. grew its stake in shares of Teladoc Health by 4.9% during the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock worth $274,000 after acquiring an additional 1,405 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.